Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020

Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020–December 2020

Published:2021-07-15 Issue:Supplement_1 Volume:73 Page:S54-S57
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Shah Melisa M¹²,Salvatore Phillip P¹²,Ford Laura¹²,Kamitani Emiko¹,Whaley Melissa J¹,Mitchell Kaitlin¹³,Currie Dustin W¹²,Morgan Clint N¹,Segaloff Hannah E¹²⁴,Lecher Shirley¹,Somers Tarah¹,Van Dyke Miriam E¹²,Bigouette John Paul¹²,Delaney Augustina¹,DaSilva Juliana¹,O’Hegarty Michelle¹,Boyle-Estheimer Lauren¹,Abdirizak Fatima¹,Karpathy Sandor E¹,Meece Jennifer⁵,Ivanic Lynn⁵,Goffard Kimberly⁶,Gieryn Doug⁶,Sterkel Alana⁷,Bateman Allen⁷,Kahrs Juliana⁸,Langolf Kimberly⁸,Zochert Tara⁸,Knight Nancy W¹,Hsu Christopher H¹,Kirking Hannah L¹,Tate Jacqueline E¹

Affiliation:

1. COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

3. Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

4. Wisconsin Department of Health Services, Madison, Wisconsin, USA

5. Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA

6. Winnebago County Health Department, Oshkosh, Wisconsin, USA

7. Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA

8. University of Wisconsin-Oshkosh, Oshkosh, Wisconsin, USA

Abstract

Abstract Repeating the BinaxNOW antigen test for severe acute respiratory syndrome coronavirus 2 using 2 groups of readers within 30 minutes resulted in high concordance (98.9%) in 2110 encounters. Same-day repeat antigen testing did not significantly improve test sensitivity (77.2% to 81.4%) while specificity remained high (99.6%).

Funder

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab309/37533357/ciab309.pdf

Reference12 articles.

1. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees;James;Infect Control Hosp Epidemiol,2021

2. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting;Okoye;J Clin Microbiol,2021

3. Evaluation of Abbott BinaxNOW rapid antigen rest for SARS-CoV-2 infection at two community-based testing sites - Pima County, Arizona, 3–17 November 2020;Prince-Guerra;MMWR Morb Mortal Wkly Rep,2021